Trending Now
BioLineRx Ltd. (NASDAQ: BLRX) Completes pre-NDA meeting on Motixafortide as a...
BioLineRx Ltd. (NASDAQ: BLRX) has announced the completion of a successful pre-NDA (New Drug Application) meeting with the US FDA about Motixafortide as a...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Aytu BioScience Inc. (NASDAQ:AYTU) Announces The Improvement Of Nastesto To Preferred...
Aytu BioScience Inc. (NASDAQ:AYTU) announced that Express Scripts Inc., which is among leading pharmacy benefit managers in the US, will make testosterone nasal gel,...
MAKE IT MODERN
LATEST REVIEWS
Qualigen Therapeutics Inc (NASDAQ: OLGN) Presents Three Posters at the American...
Qualigen Therapeutics (NASDAQ: OLGN) announced the presentation of three posters at the American Association of Cancer Research, New Orleans.
MAKE IT MODERN
PERFORMANCE TRAINING
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has Acquired New R&D Center
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) announced that the group had acquired a new research and development center, measuring close to 48,000 square feet;...
Why ISWH is a Bargain Waiting to be Tapped
ISW Holdings Inc (OTCMKTS:ISWH) is trading at $0.20 per share as one of the only pure-play leaders in outpatient care in a region currently...
Personalis Inc. (NASDAQ:PSNL) Extends Contract With VA MVP and Receives New Task Order Of...
Personalis Inc. (NASDAQ:PSNL) has announced the exercising by that the US Department of Veterans Affairs Million Veteran Program (VA MVP) of the option of...
Pot Stock Outperformance and How to Play It (GRWG, MEDH, TLRY)
The monster combination of Aphria and Tilray is a loadstone that has sparked a faith-based move by investors into the cannabis space...
Immunomedics, Inc. (NASDAQ:IMMU) Reports Revenues Of $20.1 Million In Q2 2020: Trodelvy Demonstrates Significant...
Immunomedics, Inc. (NASDAQ:IMMU) posted $20.1 million in revenues in Q2 2020 from the sale of Trodelvy after receiving accelerated approval from the US FDA...
MAKE IT MODERN
